📰 Interim Data From News
Interim Data From News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Data From. Real-time updates on events, politics, business and more.
September 4, 2023
New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life when compared to baseline Clinically important improvements seen for all...
May 31, 2023
– 12 accepted abstracts highlight Company’s emerging leadership in narcolepsy – – Data adds to growing body of evidence demonstrating positive clinical benefit and patient... | June 10, 2023
September 15, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present seven abstracts from across its neuroscience portfolio at...
June 1, 2022
Seventeen abstracts debut new data across narcolepsy and idiopathic hypersomnia DUBLIN, June 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company
June 1, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 17 new abstracts from across its...